Medicinski Glasnik (Feb 2011)
Evaluation and treatment of cardiovascular diseases in patients on hemodialysis – single center experience
Abstract
Aim To evaluate frequency of CVD in dialysis population, in relationship to patients with and without diabetes, and their mostcommon treatment. Patients and methods This retrospective study included 187 patients, 106 males and 81 females, divided in two groups, diabetics and non-diabetics, treated by chronic hemodialysis. Patients’ analyses included: anamnesis, ECG, chest X rays, echocardiogram, laboratory examinations for calcium (Ca), phosphorus (P), parathormone (PTH), cholesterol (chol), triglicerids (TG), C-reactive protein (CRP), hemoglobin (Hb) and uric acid. In addition, we analyzed groups of drugs used by patients as prescribed by cardiologists. Results Average age was 58.0 years, most of them between 51 and 60. Average hemodialysis length was 4 years. Primary kidney diseases were pyelonephritis and glomerulonephritis. 19,78% ofpatients had diabetes. 165 patients (88,23%) had one or more cardiovascular diseases. 110 patients (58,2%) had hypertension, mostof them used ACE inhibitors. Using test of multiple correlation,statistically signiicant correlations, among others, were shown between BMI and Ca, uric acid and P, albumin and PTH in diabetics, at the statistical signiicance level at p<0,05. Conclusion Cardiovascular diseases are the most common comorbidity and cause of mortality in hemodialysis population. There was no statistical signiicance in age, however there is a statistical difference in the dialysis duration variable, but in some biochemical laboratory parameters there was some difference. ACE inhibitors were most commonly used in the treatment of hypertension and systolic dysfunction, alone or with beta-blockers.
